SCHEMBL4075735

SCHEMBL4075735

CC(C)[C@H](NC(=O)c1ccccc1)C(=O)NCNC(=O)[C@@H](NC(=O)c1ccccc1)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
KMT2A Q03164 3/20 0.61
HSPA5 P11021 1/20 0.58
HSPA9 P38646 1/20 0.58
HTT P42858 1/20 0.58
MEN1 O00255 2/20 0.57
LMNA P02545 2/20 0.57
GAA P10253 1/20 0.55
POLB P06746 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.51
PPARG P37231 1/20 0.50
PPARA Q07869 1/20 0.50
MAPK1 P28482 1/20 0.50
CTSL P07711 2/20 0.49
CTSB P07858 1/20 0.49
CTSS P25774 1/20 0.49
CTSK P43235 1/20 0.49
RAB9A P51151 1/20 0.49
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6659077 0.88 KMT2A (0.58) ALDH1A1KMT2AHSPA5HSPA9HTT
SCHEMBL6659071 0.88 KMT2A (0.58) ALDH1A1KMT2AHSPA5HSPA9HTT
SCHEMBL10040931 0.86 CTSL (0.60) ALDH1A1KMT2AMEN1GAAPOLB
SCHEMBL4068014 0.83 GAA (0.58) ALDH1A1KMT2AHTTMEN1LMNA
SCHEMBL7417071 0.83 KMT2A (0.64) ALDH1A1KMT2AHSPA5HSPA9HTT
SCHEMBL19781296 0.83 KMT2A (0.64) ALDH1A1KMT2AHSPA5HSPA9HTT
SCHEMBL17384669 0.83 L3MBTL1 (0.54) ALDH1A1KMT2AHSPA5HSPA9HTT
SCHEMBL7677630 0.82 ALDH1A1 (0.62) ALDH1A1KMT2AHSPA5HSPA9HTT
SCHEMBL7677634 0.82 ALDH1A1 (0.62) ALDH1A1KMT2AHSPA5HSPA9HTT
SCHEMBL9462009 0.81 SLC1A2 (0.66) ALDH1A1KMT2AHSPA5HSPA9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207107-B2 Di-amido gellant for use in consumer product compositions THE PROCTER & GAMBLE COMPANY (US) 2012-06-26 US disclosed
US-8168579-B2 Fluid detergent compositions comprising a di-amido gellant, and processes for making THE PROCTER AND GAMBLE COMPANY (US) 2012-05-01 US disclosed
US-20110220536-A1 Fluid Detergent Compositions Comprising a Di-Amido Gellant, and Processes for Making THE PROCTER & GAMBLE COMPANY 2011-09-15 US disclosed
US-20110224455-A1 Di-Amido Gellant For Use In Consumer Product Compositions THE PROCTER & GAMBLE COMPANY 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224455-A1 Di-Amido Gellant For Use In Consumer Product Compositions DAGLA, GNPAT, CDIPT ALDH1A1 1506/4885KMT2A 3437/4885HSPA5 1691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.